Latest Articles & Resources FEATURED GI Partners Launches Rose Bio Following Charles River Acquisition Read More » GI Partners Launches Rose Bio Following Charles River Acquisition Read More » LATEST NEWS + INTERVIEWS Valion Bio Opens Velocity Bioworks Manufacturing Facility in San Antonio 3PBIOVIAN Expands Sterility Testing Capabilities for CDMO Services SK pharmteco Partners with NIH and Axle Informatics on Gene Therapy Programs CARBOGEN AMCIS Shanghai Site Passes Unannounced NMPA GMP Inspection Altasciences Partners with Certara on Model-Informed Drug Development Hovione Launches Intranasal Drug Delivery Platform Lonza Signs ADC Licensing Agreement with Bristol Myers Squibb Neuland Laboratories Partners with LIR Life on Transdermal GLP-1 Program Banyan BioInnovations Launches With $100M+ and ICON Partnership to Accelerate Clinical-Stage CRO Development Navigating Chaos: Jan Ramakers on Why the API Market Is Harder to Read Than Ever Image Analysis Group Teams With HeartcoR to Offer Single-Vendor Cardiac and Imaging CRO Solution Bart Derde on What Pharma Supply Chain Leaders Need to Succeed Novartis Finalizes US Manufacturing Expansion with New North Carolina Site Symeres Appoints Henning Steinhagen as Chief Executive Officer CTIBIOTECH Launches U.S. Subsidiary with $27M Philadelphia Expansion Made Scientific and RoosterBio Partner on MSC and EV Manufacturing Platform Viralgen Partners with Elaaj Bio on CDKL5 Gene Therapy Manufacturing Matica Biolabs Signs Stem Cell Media Manufacturing Agreement with Jeongjin Bioscience Epicrispr Biotechnologies Partners with Forge Biologics for EPI-321 Manufacturing HAS Healthcare Advanced Synthesis Signs APIC Manufacturing Agreement with Biodelphis Therapeutics AGC Biologics Expands Manufacturing Agreement for NN4101 Bispecific Antibody PODCAST INTERVIEWS Navigating Chaos: Jan Ramakers on Why the API Market Is Harder to Read Than Ever How to Manage Molecule Uncertainty: Nick Wigdahl on Portfolio Optimization and Pharma Lifecycle Strategy IPSC Manufacturing: The 30-Year Journey From Dolly the Sheep to Clinical-Grade Cell Therapies
Banyan BioInnovations Launches With $100M+ and ICON Partnership to Accelerate Clinical-Stage CRO Development
How to Manage Molecule Uncertainty: Nick Wigdahl on Portfolio Optimization and Pharma Lifecycle Strategy